Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today the U.S. Food and Drug ...
Q My mom is 61. She started having hip pain and figured it meant a hip replacement surgery at some point in the future. When ...
Osvyrti and Jubereq are FDA-approved denosumab biosimilars for osteoporosis and cancer-related skeletal events, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback